Nobuo Hirotsu Selected Research

laninamivir

2/2021	Cost-effectiveness of baloxavir marboxil compared to laninamivir for the treatment of influenza in Japan.
1/2021	Cost-effectiveness of baloxavir marboxil compared with laninamivir for the treatment of influenza in patients at high risk for complications in Japan.
1/2019	The effect of neuraminidase inhibitors on household transmission in Japanese patients with influenza A and B infection: A prospective, observational study.
1/2018	Clinical and virologic effects of four neuraminidase inhibitors in influenza A virus-infected children (aged 4-12 years): an open-label, randomized study in Japan.
5/2013	Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nobuo Hirotsu Research Topics

Disease

28	Human Influenza (Influenza) 10/2021 - 06/2003
9	Fever (Fevers) 01/2018 - 05/2005
8	Infections 01/2021 - 01/2008
3	Herpesviridae Infections (Herpesvirus Infection) 01/2018 - 06/2011
1	Pneumonia (Pneumonitis) 01/2021
1	Coinfection 01/2019
1	Reinfection 01/2013
1	Drug-Related Side Effects and Adverse Reactions 11/2011
1	Respiratory Tract Diseases (Respiratory Tract Disease) 06/2011
1	Vomiting 09/2010
1	Virus Diseases (Viral Diseases) 09/2009

Drug/Important Bio-Agent (IBA)

16	Oseltamivir (Tamiflu)FDA Link 01/2019 - 06/2003
11	Neuraminidase (Sialidase)IBA 10/2021 - 09/2009
9	Zanamivir (Relenza)FDA Link 01/2019 - 06/2007
8	baloxavirIBA 02/2021 - 01/2018
8	Antiviral Agents (Antivirals)IBA 02/2021 - 11/2011
5	laninamivirIBA 02/2021 - 05/2013
5	peramivirIBA 01/2019 - 09/2010
4	Pharmaceutical PreparationsIBA 02/2021 - 05/2005
4	AntigensIBA 01/2013 - 05/2005
2	EndonucleasesIBA 01/2019 - 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Complement System Proteins (Complement)IBA 01/2019
1	VaccinesIBA 01/2019
1	C-Reactive ProteinIBA 01/2014
1	Immunologic Factors (Immunomodulators)IBA 01/2013
1	Immunoglobulin A (IgA)IBA 01/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2013
1	benzmetanide (H 25)IBA 08/2006
1	Indicators and Reagents (Reagents)IBA 05/2005
1	Amantadine (Aman)FDA LinkGeneric 05/2005

Therapy/Procedure

7	Therapeutics 04/2012 - 08/2006
1	Aftercare (After-Treatment) 04/2012
1	Intravenous Infusions 11/2011
1	Oral Administration 11/2011
1	Intravenous Administration 09/2010